Form 4 for IDXX Idexx Laboratories
Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-03 · accession 0001567619-21-014512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-05 | 2021-08-03 | IDXX | Lane Michael | EVP | S - Sale+OE | $691.62 | -6,999 | 4,534 | -61% | -$4.84M |
| DM | 2021-08-05 | 2021-08-03 | IDXX | Lane Michael | EVP | M - OptEx | $114.59 | +6,999 | 10.6K | +192% | +$802.0K |
| DM | 2021-08-05 | 2021-08-03 | IDXX | Lane Michael | EVP | M - OptEx | — | -6,999 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-03 | S | D | 60 | $692.56 | 3,648.28 | D | — | — | (F17) Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-08-03 | S | D | 1 | $693.17 | 3,647.28 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-03 | S | D | 100 | $691.19 | 3,708.28 | D | — | — | (F16) Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2021-08-03 | S | D | 153 | $689.51 | 3,808.28 | D | — | — | (F15) Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2021-08-03 | S | D | 299 | $688.51 | 3,961.28 | D | — | — | (F14) Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2021-08-03 | S | D | 84 | $687.59 | 4,280.28 | D | — | — | (F13) Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2021-08-03 | S | D | 60 | $692.65 | 4,344.28 | D | — | — | (F12) Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2021-08-03 | S | D | 100 | $691.35 | 4,404.28 | D | — | — | (F11) Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2021-08-03 | S | D | 30 | $690.33 | 4,504.28 | D | — | — | (F10) Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 10 | Common | Common Stock | 2021-08-03 | M | A | 1,472 | $67.85 | 5,119.28 | D | — | — | (F1) Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. |
| 11 | Common | Common Stock | 2021-08-03 | M | A | 1,091 | $67.85 | 6,210.28 | D | — | — | |
| 12 | Common | Common Stock | 2021-08-03 | M | A | 4,436 | $141.60 | 10,646.28 | D | — | — | |
| 13 | Common | Common Stock | 2021-08-03 | S | D | 2,451 | $690.20 | 8,195.28 | D | — | — | (F2) Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 14 | Common | Common Stock | 2021-08-03 | S | D | 250 | $691.54 | 7,945.28 | D | — | — | (F3) Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 15 | Common | Common Stock | 2021-08-03 | S | D | 363 | $692.85 | 7,582.28 | D | — | — | (F4) Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 16 | Common | Common Stock | 2021-08-03 | S | D | 1,447 | $693.73 | 6,135.28 | D | — | — | (F5) Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 17 | Common | Common Stock | 2021-08-03 | S | D | 916 | $694.79 | 5,219.28 | D | — | — | (F6) Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 18 | Common | Common Stock | 2021-08-03 | S | D | 100 | $695.50 | 5,119.28 | D | — | — | |
| 19 | Common | Common Stock | 2021-08-03 | S | D | 95 | $687.47 | 5,024.28 | D | — | — | (F7) Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 20 | Common | Common Stock | 2021-08-03 | S | D | 245 | $688.54 | 4,779.28 | D | — | — | (F8) Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 21 | Common | Common Stock | 2021-08-03 | S | D | 245 | $689.43 | 4,534.28 | D | — | — | (F9) Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 22 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-03 | M | D | 4,436 | — | 1,512 | D | $141.60 · — to 2027-02-13 | 4,436 Common Stock | (F22) Not applicable. (F21) Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018. |
| 23 | Derivative | Incentive Stock Option (right-to-buy) | 2021-08-03 | M | D | 1,472 | — | 462 | D | $67.85 · — to 2026-02-13 | 1,472 Common Stock | (F22) Not applicable. (F19) Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. |
| 24 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2021-08-03 | M | D | 1,091 | — | 0 | D | $67.85 · — to 2026-02-13 | 1,091 Common Stock | (F22) Not applicable. (F20) Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. |